News

ACIP panel given new guidance to shape vaccine recommendations

The shift comes after a federal court struck down sweeping changes to the pediatric vaccine schedule that went into effect in 2026. The committee of medical experts, which advises on policy at the Centers for Disease Control and Prevention (CDC), will have to focus on a cost-benefit analysis in its future analyses.

Nuanced clinical reasoning remains beyond the ken of frontier LLMs

Harvard researchers put 21 state-of-the-art large language models through their paces. The results are in.

Video interview with Society for Cardiovascular Angiography and Interventions (SCAI) President Srihari S. Naidu, MD, FACC, FAHA, MSCAI, explains the advancements in interventional cardiology the society has championed over the past year. #SCAI

Outgoing SCAI president reflects on a busy year full of partnerships and advocacy

SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, made a major impact on the group—and cardiology as a whole—over the last 12 months.

FDA clears next-gen device for left-heart access

Early data linked the device with short crossing times, reduced fluoro exposure and no device-related adverse events.

Heartflow sues cardiology AI rival Cleerly over alleged patent infringement

According to Heartflow, Cleerly's actions represent “one of the most egregious examples of piracy in the medical technology industry.” Cleerly commented on the lawsuit, defending the value and integrity of its products.

Heartflow artificial intelligence CCTA images

Imaging AI vendor Heartflow sues competitor over alleged patent infringement

The Mountain View, California-based company—which creates personalized models of the heart from CT scans—is taking rival Cleerly to court.

Supporters vs. denouncers of the White House’s proposed 2027 budget: Voices heard in or near healthcare circles

If the budget makes it through Congress intact as submitted—a big if even with the president’s party in the majority in both chambers—healthcare is in for some strict belt-tightening.

Microbot Medical LIBERTY robotic endovascular system

Emory Healthcare IRs 1st in the world to use newly approved robotic system for liver, prostate procedures

The system was cleared by the U.S. Food and Drug Administration in September and was adopted by the interventional team at Atlanta-based Emory shortly after.

The balloon-expandable Myval transcatheter aortic valve replacement (TAVR) valve is associated with positive real-world data after four years.

Myval TAVR valve associated with positive durability data after 4 years

Researchers have been spending more and more time evaluating the Myval TAVR valve from Indian medtech company Meril Life Sciences. The balloon-expandable device is available in some parts of the world, but not the United States.

Experts create AI system that can accurately diagnose osteoporosis using routine X-rays

Experts are optimistic their tool could help providers identify patients who may be at risk of developing osteoporosis sooner.

After nearly shutting down its entire interventional department, radiologists throw hospital a lifeline

Despite all of its IR providers submitting their resignations in June, a hospital in Australia appears to have avoided the complete shutdown of the department (for now).

An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.

Medicare now covers TriClip procedures for patients with symptomatic tricuspid regurgitation

CMS has finalized a new national coverage determination for T-TEER, sometimes known as transcatheter tricuspid valve repair. Abbott's TriClip is the only device approved by the FDA for T-TEER, but other treatment options are under development.

Around the web

Health Exec

ACIP panel given new guidance to shape vaccine recommendations